Digyaindoleacid A: 2-(1-(4-hydroxyphenyl)-3-oxobut-1-en-2-yloxy)-3-(1H-indol-3-yl)propanoic acid, a novel indole alkaloid

MakaleAçık ErişimScopus SJRQ4
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Digyaindoleacid A (1) is one of the novel alkaloids produced by the Ghanaian Paenibacillus sp. DE2SH (GenBank Accession Number: MH091697) isolated from the mangrove rhizosphere soils of the Pterocarpus santalinoides tree growing in the wetlands of the Digya National Park, Brong Ahafo Region, Ghana. This compound was isolated on HPLC at tR ≈ 60 min and its structure determined by MS, 1D, and 2D-NMR data. When tested against Trypanosoma brucei subsp. brucei strain 927/4 GUTat10.1, 1 produced a half-maximal inhibitory concentration (IC50) 5.21 µM compared to the standard diminazene aceturate (IC50 = 1.86 µM). In the presence of normal mouse macrophages RAW 264.7, 1 displayed a higher selectivity towards T. brucei subsp. brucei (selectivity indices (SI) = 30.2) with low toxicity. This result is interesting given that the drug diminazene aceturate is considerably toxic and 1 is a natural product isolate. The structure of 1 incorporates the backbone of the amino acid tryptophan which is crucial in the metabolism of Trypanosoma brucei subsp. brucei strain 927/4 GUTat10.1. It is possible that 1, could interfere with the normal uptake and metabolism of tryptophan in the parasite. However, 1 (IC50 = 135.41 µM) produced weak antileishmanial activity when tested against Leishmania donovani (Laveran and Mesnil) Ross (D10).

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/munzur/3629Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.3390/m1080Yayıncı resmi DOI adresi
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
4
WoS
3
OpenAlex
4
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorKwain, Samuel
dc.contributor.authorTetevi, Gilbert Mawuli
dc.contributor.authorMensah, Thomas
dc.contributor.authorCamas, Anil Sazak
dc.contributor.authorCamas, Mustafa
dc.contributor.authorDofuor, Aboagye Kwarteng
dc.contributor.authorAzerigyik, Faustus Akankperiwen
dc.contributor.authorDeng, Hai
dc.contributor.authorJaspars, Marcel
dc.contributor.authorKyeremeh, Kwaku
dc.date.accessioned2026-10-28T14:56:52.852765706Z
dc.date.available2026-10-28T14:56:52.852765706Z
dc.date.issued2019
dc.description.abstractDigyaindoleacid A (1) is one of the novel alkaloids produced by the Ghanaian Paenibacillus sp. DE2SH (GenBank Accession Number: MH091697) isolated from the mangrove rhizosphere soils of the Pterocarpus santalinoides tree growing in the wetlands of the Digya National Park, Brong Ahafo Region, Ghana. This compound was isolated on HPLC at tR ≈ 60 min and its structure determined by MS, 1D, and 2D-NMR data. When tested against Trypanosoma brucei subsp. brucei strain 927/4 GUTat10.1, 1 produced a half-maximal inhibitory concentration (IC50) 5.21 µM compared to the standard diminazene aceturate (IC50 = 1.86 µM). In the presence of normal mouse macrophages RAW 264.7, 1 displayed a higher selectivity towards T. brucei subsp. brucei (selectivity indices (SI) = 30.2) with low toxicity. This result is interesting given that the drug diminazene aceturate is considerably toxic and 1 is a natural product isolate. The structure of 1 incorporates the backbone of the amino acid tryptophan which is crucial in the metabolism of Trypanosoma brucei subsp. brucei strain 927/4 GUTat10.1. It is possible that 1, could interfere with the normal uptake and metabolism of tryptophan in the parasite. However, 1 (IC50 = 135.41 µM) produced weak antileishmanial activity when tested against Leishmania donovani (Laveran and Mesnil) Ross (D10).
dc.description.sponsorshipMedical Research Council, MRC
dc.description.sponsorshipCambridge-Africa Partnership for Research Excellence
dc.description.sponsorshipUniversity of Ghana, UG
dc.description.sponsorshipDepartment for International Development, UK Government, DFID
dc.description.sponsorshipCarnegie Corporation of New York, CCNY
dc.description.sponsorshipBANGA
dc.description.sponsorshipThe World Academy of Sciences, TWAS, (Award_17-512 RG/CHE/AF/AC_G)
dc.description.sponsorshipThe World Academy of Sciences, TWAS
dc.description.sponsorshipUK Research and Innovation, UKRI, (MR/S00520X/1)
dc.description.sponsorshipUK Research and Innovation, UKRI
dc.identifier.articlenumberM1080
dc.identifier.doi10.3390/m1080
dc.identifier.eissn1422-8599
dc.identifier.issn1422-8599
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85075516071
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/munzur/3629
dc.identifier.volume2019
dc.identifier.wosWOS:000488250800007
dc.language.isoen
dc.publisherMDPI AG
dc.relation.ispartofMolBank
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAntileishmanials
dc.subjectAntitrypanosomals
dc.subjectCell cycle
dc.subjectCell viability
dc.subjectLeishmaniasis
dc.subjectSpectrometry
dc.subjectSpectroscopy
dc.subjectTrypanosomiasis
dc.subjectTryptophan
dc.subject.classificationChemistry, Organic
dc.subject.classificationChemistry
dc.subject.otherDISEASE
dc.titleDigyaindoleacid A: 2-(1-(4-hydroxyphenyl)-3-oxobut-1-en-2-yloxy)-3-(1H-indol-3-yl)propanoic acid, a novel indole alkaloid
dc.typeArticle
rdl.citation.openalex4
rdl.citation.scopus4
rdl.citation.wos3
rdl.oa.statusgold
rdl.oa.urlhttps://www.mdpi.com/1422-8599/2019/3/M1080/pdf?version=1569140186
rdl.scopus.quartileQ4
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexEmerging Sources Citation Index (ESCI)